Sponsored by:

Nuclear Medicine: Page 343

Neoprobe gets FDA nod for more Lymphoseek trials
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has received authorization from the U.S. Food and Drug Administration (FDA) to begin patient enrollment in two phase I clinical studies for its Lymphoseek targeting agent.
January 16, 2007
Nuclear pharmacy operators merge to form Triad Isotopes
By AuntMinnie.com staff writers
Three nuclear pharmacy operators have merged operations to form a new company, Triad Isotopes.
January 16, 2007
Digirad updates 2006 guidance
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad yesterday updated its previous financial guidance for 2006 and provided initial guidance for 2007.
January 11, 2007
SPECT/CT enhances octreotide imaging
By Jonathan S. Batchelor
Indium-111-labeled octreotide imaging has shown greater accuracy than CT or MRI scans in detecting somatostatin receptor-positive neuroendocrine tumors. But anatomic localization of these tumors solely based on octreotide scans is problematic, so these procedures are usually performed with CT or MRI. A recent study suggests that SPECT/CT in octreotide imaging can provide important diagnostic information to clinicians that is unavailable with planar whole-body scans.
January 11, 2007
IBA nets U.S. proton therapy order
By AuntMinnie.com staff writers
Belgian nuclear medicine products firm Ion Beam Applications has been selected by ProCure Treatment Centers to build a four-room proton therapy center in Oklahoma City.
January 7, 2007
Temporal subtraction technique improves diagnostic accuracy, speed
By Jonathan S. Batchelor
Although bone scintigraphy is one of the more widely used nuclear medicine studies, interpreting the images is time-intensive, and detecting interval changes can be problematic. Now researchers from Chicago have developed a computerized temporal subtraction technique used between successive whole-body bone scans that may reduce physicians' reading time and improve their accuracy.
January 3, 2007
Siemens finalizes Bayer buy
By AuntMinnie.com staff writers
Siemens Medical Solutions has completed its acquisition of Bayer Healthcare's diagnostic division.
January 2, 2007
Philips, Bioscan partner on NanoSPECT marketing
By AuntMinnie.com staff writers
Philips Medical Systems has signed an agreement giving it the rights to co-market and co-distribute molecular imaging developer Bioscan's NanoSPECT and NanoSPECT/CT devices.
January 1, 2007
Trial date set for IBA, Optivus dispute
By AuntMinnie.com staff writers
Belgian nuclear medicine products firm Ion Beam Application (IBA) is reporting that a trial date has been set in Los Angeles on the remaining claims asserted against IBA by Optivus Technology of Loma Linda, CA, and Loma Linda University Medical Center.
December 20, 2006
GE installs first Discovery STE in Canada
By AuntMinnie.com staff writers
GE Healthcare of Chalfont St. Giles, U.K,. has completed the first installation of its Discovery STE PET/CT technology in Canada.
December 20, 2006
Solid-state dual-head camera supercharges molecular breast imaging
By Jonathan S. Batchelor
Molecular breast imaging's potential for detecting malignant tumors has been constrained by different factors, such as the limitation of conventional scintimammography with Tc-99m sestamibi in detecting smaller malignant tumors. But Mayo Clinic researchers may have overcome these drawbacks by developing a solid-state dual-head gamma camera for breast imaging.
December 18, 2006
IBA to supply radiopharmaceuticals to Spain
By AuntMinnie.com staff writers
Belgian nuclear medicine products firm Ion Beam Applications (IBA) has been named by the regional health authorities in the Spanish region of Andalusia as its exclusive supplier of FDG and other radiopharmaceuticals.
December 13, 2006
Previous Page
Page 343 of 438
Next Page